These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6832751)

  • 21. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
    Stefăneanu L; Simionescu L; Aman E; Taşcă C
    Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocytochemistry of the thyroid in surgical and cytologic specimens.
    Davila RM; Bedrossian CW; Silverberg AB
    Arch Pathol Lab Med; 1988 Jan; 112(1):51-6. PubMed ID: 3337618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1.
    Katoh R; Bray CE; Suzuki K; Komiyama A; Hemmi A; Kawaoi A; Oyama T; Sugai T; Sasou S
    Hum Pathol; 1995 Feb; 26(2):139-46. PubMed ID: 7860043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroglobulin immunostaining in follicular thyroid carcinoma: relationship to the degree of differentiation and cell type.
    Harach HR; Franssila KO
    Histopathology; 1988 Jul; 13(1):43-54. PubMed ID: 3061922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
    Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
    Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid.
    Harach HR; Williams ED
    Histopathology; 1983 Jan; 7(1):83-97. PubMed ID: 6840715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
    Fucich LF; Freeman SM; Marrogi AJ
    Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
    Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
    Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemistry of thyroglobulin by indirect immunofluorescence in thyroid cancers].
    Estour B; Berger N; Bancel B; Bornet H; Rousset H; Sassolas G; Tourniaire J
    Presse Med; 1984 Nov; 13(42):2555-8. PubMed ID: 6239252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of the thyroid with a mixed medullary, papillary, follicular, and undifferentiated pattern.
    Parker LN; Kollin J; Wu SY; Rypins EB; Juler GL
    Arch Intern Med; 1985 Aug; 145(8):1507-9. PubMed ID: 3896182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B.
    Kovacs CS; Masé RM; Kovacs K; Nguyen GK; Chik CL
    Cancer; 1994 Aug; 74(3):928-32. PubMed ID: 7913660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA and thyroid carcinoma.
    Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
    Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary carcinoma of the thyroid. A histochemical, immunohistochemical and ultrastructural study with special reference to the follicular variant.
    Eimoto T; Naito H; Hamada S; Masuda M; Harada T; Kikuchi M
    Acta Pathol Jpn; 1987 Oct; 37(10):1563-79. PubMed ID: 3434281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Undetectable serum thyroglobulin due to negative interference of heterophile antibodies in relapsing thyroid carcinoma.
    Giovanella L; Ghelfo A
    Clin Chem; 2007 Oct; 53(10):1871-2. PubMed ID: 17885144
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
    Kavishwar VS; Phatak AM; Rege JD
    Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to human thyroglobulin: evaluation of immunoreactivity.
    Narkar AA; Shah DH; Yadav J; Swaroop D; Mulherkar R
    Hybridoma; 1992 Dec; 11(6):803-13. PubMed ID: 1284124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
    Schelfhout LJ; Van Muijen GN; Fleuren GJ
    Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.